Blocking PAR2 Alleviates Bladder Pain and Hyperactivity via TRPA1 Signal

Area of Science:

• Urology
• Neuroscience
• Pharmacology

Background:

• Interstitial cystitis (IC) often presents with bladder overactivity and pain.
• Proteinase-activated receptor-2 (PAR2) and transient receptor potential A1 (TRPA1) are implicated in sensory signaling.
• Cyclophosphamide (CYP)-induced cystitis in rats serves as a model for studying bladder dysfunction.

Purpose of the Study:

• To investigate the impact of blocking PAR2 on bladder hyperactivity and pain in a rat model of cystitis.
• To elucidate the mechanisms by which PAR2 influences sensory activity in the bladder.
• To explore the interplay between PAR2 and TRPA1 pathways in cystitis-induced bladder dysfunction.

Main Methods:

• Rats were induced with cystitis using systemic cyclophosphamide (CYP) administration.
• PAR2 was blocked via intrathecal infusion of a specific antagonist (FSLLRY-NH2).
• TRPA1 signaling was inhibited to assess its role and interaction with PAR2.

Main Results:

• CYP administration significantly increased PAR2 protein expression in rats.
• Intrathecal blockade of PAR2 effectively reduced bladder hyperactivity and pain.
• Blocking PAR2 also attenuated TRPA1 signaling, and TRPA1 inhibition independently decreased bladder overactivity and pain.
• These findings highlight a signaling cascade involving PAR2 and TRPA1 in CYP-induced cystitis.

Conclusions:

• PAR2 and TRPA1 activation are critical components of the signaling pathways leading to bladder hyperactivity and pain in cystitis.
• Inhibiting PAR2 and/or TRPA1 demonstrates therapeutic potential for managing cystitis-related bladder dysfunction and pain.
• Targeting these specific signaling molecules offers promising avenues for developing novel treatments for overactive bladder and pain in cystitis.